Acadian Asset Management
CDAK

Acadian Asset Management’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Acadian Asset Management’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23,915
Closed – – 1929
2023
Q2 		$0 Hold
23,915
– – ﹤0.01% 1973
2023
Q1 		$3K Hold
23,915
– – ﹤0.01% 1704
2022
Q4 		$9K Hold
23,915
– – ﹤0.01% 1742
2022
Q3 		$18K Buy
+23,915
New +$50.2K ﹤0.01% 1611

Acadian Asset Management's CDAK Position: Q3 2023 in Review

Acadian Asset Management sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q3 2023, closing a stake of 23,915 shares.

Acadian Asset Management first reported a position in CDAK in Q3 2022 and held it in 4 quarters. The position peaked at $18K in Q3 2022. 0 funds tracked by Wall St. Rank hold CDAK as of Q3 2023.

  • Acadian Asset Management reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Acadian Asset Management sold 23,915 Codiak BioSciences, Inc. Common Stock shares in Q3 2023.
  • Acadian Asset Management first reported a position in Codiak BioSciences, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Acadian Asset Management's Codiak BioSciences, Inc. Common Stock position peaked at $18K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q3 2023.

Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.